We are live on ! Find out more
Geode Capital Management

Geode Capital Management Portfolio holdings

AUM $1.61T
1-Year Est. Return 30.72%
 

Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.

This Fund
S&P 500
This Quarter Est. Return
+9.26%
1 Year Est. Return
+30.72%
3 Year Est. Return
+105.46%
5 Year Est. Return
+141.95%
10 Year Est. Return
+548.24%
AUM
$726B
AUM Growth
+$72B
Cap. Flow
+$18.3B
Cap. Flow %
2.52%
Top 10 Hldgs %
22.02%
Holding
4,790
New
331
Increased
3,384
Reduced
720
Closed
74

Sector Composition

Rank Sector Weight
1 Technology 23.98%
2 Financials 13.87%
3 Healthcare 13.39%
4 Consumer Discretionary 11.81%
5 Communication Services 10.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NCNA
4676
NuCana
NCNA
$5.24M
$40K ﹤0.01%
3
TRIB
4677
Trinity Biotech
TRIB
$8.61M
$40K ﹤0.01%
93
SCNI
4678
Scinai Immunotherapeutics
SCNI
$1.43M
$39K ﹤0.01%
138
XTKG
4679
DELISTED
X3 Holdings Co., Ltd. Class A Ordinary Shares
XTKG
0
QNRX
4680
Quoin Pharmaceuticals
QNRX
$8.84M
0
SXTC icon
4681
China SXT Pharmaceuticals
SXTC
$2.79M
0
TOUR
4682
Tuniu
TOUR
$54.2M
$38K ﹤0.01%
1,613
BYU
4683
DELISTED
BAIYU Holdings, Inc. Common Stock
BYU
$38K ﹤0.01%
154
EVK
4684
DELISTED
Ever-Glory International Group, Inc.
EVK
$38K ﹤0.01%
13,112
-6,061
-32% -$14.8K
ALAR
4685
Alarum Technologies
ALAR
$12.3M
$37K ﹤0.01%
2,488
GDC icon
4686
GD Culture Group
GDC
$6.54M
$37K ﹤0.01%
2
PME
4687
DELISTED
Pingtan Marine Enterprise Ltd.
PME
$37K ﹤0.01%
41,107
DUO
4688
Fangdd Network Group
DUO
$22.6M
$36K ﹤0.01%
3
PXS icon
4689
Pyxis Tankers
PXS
$48.5M
$36K ﹤0.01%
10,641
-5,111
-32% -$18K
XTNT icon
4690
Xtant Medical Holdings
XTNT
$60.6M
$34K ﹤0.01%
21,204
YTRA icon
4691
Yatra Online
YTRA
$52.2M
$33K ﹤0.01%
+14,712
New +$32.9K
BETS
4692
DELISTED
Bit Brother Limited Class A Ordinary Shares
BETS
$33K ﹤0.01%
1
AIU
4693
DELISTED
Meta Data Limited American Depositary Shares, each representing ten (10) Class A Ordinary Shares
AIU
$32K ﹤0.01%
213
AEHL icon
4694
Antelope Enterprise Holdings
AEHL
$9.17M
$31K ﹤0.01%
4
-2
-33% -$14K
AEY
4695
DELISTED
ADDvantage Technologies Group
AEY
$31K ﹤0.01%
1,193
PZG icon
4696
Paramount Gold Nevada
PZG
$99.5M
$29K ﹤0.01%
30,702
BLRX
4697
BioLineRX
BLRX
$11.7M
$28K ﹤0.01%
257
NBRV
4698
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$28K ﹤0.01%
843
+314
+59% +$11.7K
CIG icon
4699
CEMIG Preferred Shares
CIG
$6.21B
$27K ﹤0.01%
19,682
+402
+2% +$555
DTSS icon
4700
Datasea Intelligent Technology Ltd
DTSS
$8.1M
$26K ﹤0.01%
699

Similar funds

Geode Capital Management's Q2 2021 Portfolio in Review

As of Q2 2021, Geode Capital Management held 4,790 positions worth $726B, up 11% from $654B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Geode Capital Management's Q2 2021 filing shows 331 new, 3,384 increased, 720 reduced and 74 closed positions. Its largest new stake was Organon & Co: 5,070,121 shares worth $153M. The largest sale was Sherwin-Williams, an estimated $1.88B.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.

  • Geode Capital Management's largest Q2 2021 buy was Organon & Co: 5,070,121 shares worth $153M.
  • Geode Capital Management added most to Microsoft in Q2 2021, an estimated $786M increase.
  • Geode Capital Management's biggest Q2 2021 reduction was Sherwin-Williams, cutting an estimated $1.88B.
  • Geode Capital Management fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $274M.
  • Geode Capital Management's ten largest holdings make up 22% of its $726B portfolio in Q2 2021.
  • Geode Capital Management opened 331 new positions and closed 74 in Q2 2021.
  • Geode Capital Management's portfolio value rose 11% quarter-over-quarter to $726B.

Based on Geode Capital Management's 13F filing for Q2 2021, filed 13 Aug 2021.